GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)
India · Delayed Price · Currency is INR 2,936.50
-226.10 (-7.15%)
Aug 1, 2025, 3:30 PM IST
Verve Therapeutics Market Cap
NSE:GLAXO has a market cap or net worth of 497.02 billion as of August 1, 2025. Its market cap has increased by 12.34% in one year.
Market Cap
497.02B
Enterprise Value
472.14B
Revenue
37.48B
Ranking
n/a
PE Ratio
52.30
Stock Price
$2,936.50
Market Cap Chart
Since October 25, 2001, NSE:GLAXO's market cap has increased from 19.14B to 497.02B, an increase of 2,496.75%. That is a compound annual growth rate of 14.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 497.02B | 30.28% |
| Dec 31, 2024 | 381.50B | 18.69% |
| Dec 29, 2023 | 321.43B | 43.86% |
| Dec 30, 2022 | 223.43B | -25.08% |
| Dec 31, 2021 | 298.24B | 8.46% |
| Dec 31, 2020 | 274.98B | 0.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,910.20B |
| Divi's Laboratories | 1,688.78B |
| Cipla | 1,213.89B |
| Mankind Pharma | 1,059.19B |
| Apollo Hospitals Enterprise | 1,057.03B |
| Zydus Lifesciences | 954.97B |
| Fortis Healthcare | 648.70B |
| Aurobindo Pharma | 627.15B |